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ABSTRACT 
This paper presents a comprehensive summary of the literature surrounding transgender primary 
and preventive healthcare and recommendations for professional medical staff and researchers. 
The public health significance of this issue is that there are an estimated 1.2 million transgender 
adults living in the United States at the time of this research. Formal epidemiological 
measurements of the population as well as the incidence and prevalence of gender dysphoria 
throughout the life course are missing from the literature. Transgender patients face a unique 
combination of healthcare access barriers and therefore are less likely than the general 
population to seek treatment. Access barriers include personal attitudes and beliefs, interpersonal 
interactions resulting in discrimination, and structural barriers such as lack of insurance 
coverage. Delays in primary and preventive medical care are associated with poorer health 
outcomes across all populations. Because of their unique vulnerabilities, transgender patients 
require medical care that is comprehensive and sensitive to the needs of individuals who are 
transgender. Rigorous research and improved medical practices can offset the minority stress and 
associated medical concerns faced by this community in the long-term.   
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1.0  INTRODUCTION 
 The purpose of this study is to identify the current research gaps, medical knowledge 
deficits, and medical practice and policy needs specific to healthcare consumers who are 
transgender. This will also include identifying current standards of practice, and establishing best 
practice guidelines for those areas that are less well-developed. This critical literature synthesis 
focuses on primary and preventive care in a holistic sense, instead of the more well-researched 
(but still notably insufficient) transition-specific care. It is of note that some deficits extend into 
the realm of gender confirmation, such as research into hormone therapy and gender 
confirmation surgery, but these will not be the primary focus of this paper.  
It is of note that many practitioners in the field are now using the term “gender-
expansive” to describe the entire spectrum of identities incongruent with sex assigned at birth. 
This term is not currently reflected in the literature, but will be used here during the course of the 
recommendations section. Since many people do not identify as transgender but may have an 
identity not congruent with assigned sex, this term is more inclusive of the entire community. 
When discussing those who identify as gender-expansive, acronyms such as “FTX” or “MTX” 
will be used. These indicate sex assigned at birth (M for male, F for female), to (“T”), and X for 
any variation of gender identity. These acronyms are used infrequently in the literature. More 
common are the acronyms MTF and FTM (male-to-female and female-to-male) to indicate 
binary transition.  
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This paper will explore the perceived barriers to quality healthcare identified by both 
patients and providers as described in the extant literature. Attention will be given to current 
standards of practice, and how to incorporate them into current medical practice. This will also 
show how individuals who identify as transgender or gender expansive have been systematically 
excluded from existing medical studies. Erasure will be discussed in regards to not only medical 
research, but also medical education and ongoing training. The paper will conclude with 
recommendations across seven specific categories: staff training, healthcare environment, 
medical documentation, general care, insurance policies, medical education, and research 
needed.  
1.1 STATEMENT OF NEED 
 The estimated number of people who identify as transgender has increased over the last 
several years. This increase may be an artifact based on people’s comfort in coming 
out/identifying as transgender, a broader available vocabulary for the many identities one may 
experience, and more reliable data-collection through respondent-driven sampling. Information 
from 2011 suggests a global population of approximately 25 million people who identify as 
transgender (1). It is of note that this is an extrapolation to a global population of 5.1 billion, and 
used the lowest reported estimate of people who identified as transgender. This does not directly 
state inclusion of all gender-expansive identities.  
 In the United States estimates of the transgender population are provided by The 
Williams Institute, using the Behavioral Risk Factor Surveillance Survey (BRFSS) (2). The 
BFRSS provides an optional module regarding gender identity, but is not measured in most 
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states. This was first implemented in the 2014 survey. Those results showed that there are at least 
1.4 million transgender adults living in the United States (2). The numbers also suggested that 
among younger adults, the prevalence of transgender identity is higher.  
It has been well-established through research that the lesbian, gay, bisexual, and transgender 
(hereafter referred to as LGBT) population experiences poorer health outcomes than the general 
population (3). In addition, a closer look at the evidence suggests that there are significant 
within-group disparities between the LGB population and the transgender population in relation 
to healthcare services, access, and primary care utilization (4, 5).  
 Surveys of transgender people have yielded numerous concerning statistics regarding 
healthcare. These individuals report being unable to access trans-inclusive primary and 
emergency care as a main health concern (6), and even when care is accessed, pervasive 
discrimination across all healthcare systems has been reported (4). One author summarizes these 
disparities as a call to action:  
 
“In a recent survey… over 21% [of transgender adults] were denied mental health 
services, 15% were denied gender-specific care (such as Pap smears for 
transgender men), and 10% were denied primary health care. Disturbingly, in a 
national report, over 70% of transgender adults reported harsh or abusive 
language, blame for their health status, or physical roughness or abuse from 
health care professionals. Unsurprisingly, 90% of transgender individuals agree 
that there are ‘not enough health professionals adequately trained to care for 
transgender people.’” (7) 
 4 
1.2 SOCIAL DETERMINANTS OF HEALTH 
Social determinants and health system determinants both contribute to limited healthcare access. 
The World Health Organization (WHO) defines determinants of health as a set of circumstances 
or the combination of environmental, genetic, and social factors that affect an individual’s 
health(8). It is well-documented that the transgender population faces issues with social support, 
employment conditions, housing conditions, income level, and social status (4, 9-13). Research 
has shown that “poverty, homelessness, stigma, addiction, violence, untreated mental health 
problems, lack of employment opportunities, powerlessness, lack of choice, lack of legal status, 
and lack of social support create an environment in which…illnesses flourish and spread” (6). 
All of the barriers listed are current challenges faced by the transgender community, as 
demonstrated in existing literature.  
 People who identify as transgender have an increased risk of suicide compared to the 
general population. Percentages of those attempting suicide are 41% and less than 2%, 
respectively (4). The minority stress model has been used to explain higher rates of suicide 
attempts among the LGB population (14). This model indicates that people with multiple layers 
of marginalization (for example, someone who is in the LGBTQ community and is also a racial 
or ethnic minority) will experience poorer health outcomes than someone in one or more 
dominant groups (someone who is cisgender, heterosexual, and/or in the racial majority) (3). 
This model could be further applied to the poor health outcomes of transgender individuals 
compared to the general population, but has not been rigorously studied to date.  
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1.2.1 Stigma 
Stigma and discrimination are positively associated with suicide attempts in the 
transgender population (15) and are positively associated with negative health outcomes in other 
populations (13). Stigma can occur for a number of reasons within the transgender community, 
including adherence to binary norms (16). Even when one’s status as a transgender person is 
accepted, the individual may still be expected to act “feminine enough” or “masculine enough” 
to be accepted as their true gender. People with non-binary identities and those who are gender 
non-conforming experience stigma for challenging the idea that an individual must present as 
male or female (16). This also manifests in healthcare settings, which will be discussed later in 
this paper.  
Stigma is pervasive, and can be examined at each layer of the social ecological model. 
White Hughto et al. (12) describe in detail multiple levels of stigma and how each impacts the 
transgender population (Figure 1). This ranges from individual beliefs and behaviors (including 
internalized stigma), to interpersonal interactions, and then to structural norms, laws, policies, 
etc.  
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Used with permission from the author. 
On an individual level, people often internalize negative associations toward their own 
group. A person may avoid coming out as transgender due to beliefs that it is unnatural, that it is 
a phase that they will grow out of, or that others in their life will not accept them as their 
identified gender.  
Interpersonal conflict is something that plagues everyday interactions for transgender 
people. Some days these may include misgendering microaggressions—other people using the 
incorrect pronouns to describe a person. Other days it may manifest in rejection from family, 
Figure 1. Social Ecological Model of stigma 
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social groups, etc. At the worst, physical and sexual assault are regularly reported by transgender 
individuals, and experienced at much higher rates than other populations (4).  
Structural stigma will be the main focus of this analysis, as it is the most relevant to 
research gaps and healthcare practices. Multiple studies have reflected the need for people who 
are transgender to educate their medical providers regarding their unique medical needs (4, 6). 
The managing uncertainty and establishing authority theory (Figure 2) suggests that this lack of 
medical knowledge could be a driving force behind negative treatment and stigma among 
healthcare providers (11). As shown below, the core of interaction between a patient and medical 
provider rests on power relations. Usually, the medical provider retains power over the patient 
due to a wider medical knowledge base. Stigma against the patient results in reinforcing the 
power relations, whereas ambivalence and uncertainty on the part of the provider challenges 
them. If a provider needs to ask a patient about their medical needs, the provider loses authority. 
Power shifts to the patient as the patient and provider resist stigma (both internalized and 
interpersonal), and the provider’s uncertainty regarding care increases. This shift in power is 
proposed to contribute to the medical provider participating in interpersonal discrimination as a 
way to retain control over the interaction (11). Such interaction jeopardizes the relationship 
between the two, and may also lead to reinforced stigma on either side (interpersonal stigma 
from the provider, internalized stigma from the patient) (11).  
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Used with permission from the author 
Figure 2. Managing uncertainty and establishing authority 
 
The above model is based on the idea of knowledge legitimacy, and how the transgender 
community simultaneously upholds and challenges current medical knowledge (17). Many 
medical providers have limited experience in treating transgender clients, and therefore patients 
have to tell their provider about their transition-related medical needs. This includes but is not 
limited to information about hormone therapy, one’s gender identity and pronouns, one’s sexual 
orientation, sexual behavior, and associated risk factors.  These patients also challenge current 
practices and beliefs by educating healthcare professionals about things that are effective or 
ineffective in their care, regardless of whether they are supported practices by the medical 
community (17).  
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 Link and Phelan describe the detrimental effect of stigma on overall public health (18). 
The process of stereotyping culminates in the exercise of power over the stigmatized individuals, 
leading to stereotyping on both sides of the power dynamic (18); for example, transgender 
patients may begin to see medical providers as cold, uncaring, close-minded, or even dangerous. 
Furthermore, when discussing existing health disparities we would be remiss to forget the higher 
rates of HIV infection among people who are transgender (19). As shown in the Lambda Legal 
report, those diagnosed with HIV are also likely to experience discrimination based on disease 
status (5). Herbst et al. showed intersectional disparities within the transgender population, and 
found that the highest rates of HIV infection were among transgender people of color (19). This 
further upholds the minority stress model applied to this population. Multiple layers of 
stigmatization lead to poorer health outcomes, and this is no different within the transgender 
community (3).  
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2.0  METHODS OF DATA COLLECTION 
 Articles were collected through the PubMed database. The focus was to find articles that 
had measured primary and preventive healthcare concerns for people who identify as transgender 
or gender expansive. This also included emergency care for general conditions, or conditions not 
related to transition. The following search terms were used (Table 1). 
Table 1. Search Terms 
Field 1 "transgender persons"[MeSH Terms] 
OR ("transgender"[All Fields] AND 
"persons"[All Fields]) OR 
"transgender persons"[All Fields] OR 
"transgender"[All Fields]) OR 
transsexual[All Fields] 
 
 
Field 2 "primary health care"[MeSH Terms] 
OR ("primary"[All Fields] AND 
"health"[All Fields] AND "care"[All 
Fields]) OR "primary health care"[All 
Fields] OR ("primary"[All Fields] AND 
"care"[All Fields]) OR "primary 
care"[All Fields]) OR ("preventive 
medicine"[MeSH Terms] OR 
("preventive"[All Fields] AND 
"medicine"[All Fields]) OR 
"preventive medicine"[All Fields] OR 
("preventive"[All Fields] AND 
"care"[All Fields]) OR "preventive 
care"[All Fields] 
 
 
Field 3 "health"[MeSH Terms] OR 
"health"[All Fields]) OR ("delivery of 
health care"[MeSH Terms] OR 
("delivery"[All Fields] AND 
"health"[All Fields] AND "care"[All 
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Fields]) OR "delivery of health 
care"[All Fields] OR "healthcare"[All 
Fields] 
 
Additional filters English language 
Published within the last 10 years 
Adult subjects (ages 18+) 
= 185 results  
 
Additional content criteria were assessed after the initial search was conducted. The 
primary focus of the article had to be on primary or preventive healthcare and not specializing in 
hormones, surgery, or other gender-confirmation procedures. The transgender population also 
had to be the only focus of the article, or was separated in the analysis from the lesbian, gay, 
and/or bisexual population. Citation mining was used following collection of articles. Of the 
initial 185 search results, approximately 12 were included in this paper. The rest were gathered 
through citation mining and external sources.  
 
 
 
Table 1 Continued 
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3.0  RESULTS 
A qualitative study of physicians examined their perceived barriers to providing high-
quality care to people who identify as transgender (20). The authors divided these into five 
categories: healthcare access, health system determinants, medical knowledge deficits, 
diagnosing vs. pathologising transgender individuals, and ethics of transition-related care (20). In 
order to address the deficiencies in healthcare faced by this population, this paper will begin by 
examining each category in detail and explore supporting research.  
3.1 HEALTHCARE ACCESS 
Healthcare access is a complex topic. Access ranges from being aware of healthcare 
services, to perceived need for services, to the actual experience of seeking healthcare. Access 
includes such things as transportation, scheduling, costs of co-pays, and the experience one has 
when seeking care. There are also multiple factors that may encourage or discourage patients 
from returning after an initial appointment. The model explored here breaks healthcare access 
down into provider factors and patient factors, and explores barriers at each stage from both sides 
of the interaction.  
 
 13 
3.1.1 Conceptual model of healthcare access 
Levesque, Harris, and Russell define access as “the opportunity to have health care needs 
fulfilled” (21). They provide a model that describes the path from health care needs to health 
care consequences, with steps in between indicating perception of health needs, care-seeking 
behaviors, and utilization of healthcare. The health belief model is nested within this framework, 
but that model alone cannot explain the full range of a patient accessing healthcare or not. The 
health belief model encompasses only the patient’s perceived need for care, feelings about 
accessing care, health literacy, and cues to seek care. As is seen in the model below, this is only a 
fraction of the full picture; the health belief model covers the first two segments of the process of 
healthcare access.  
The Levesque et al. model (Figure 3) shows the outside forces impacting behavior 
change, as well as utilization and health outcomes. Based on this model, the authors propose a 
conceptual framework of access, and discuss the barriers on both the side of the patient and the 
side of providers. Here we will discuss in detail the specific challenges faced by transgender 
individuals at all levels of healthcare access.  
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Figure 3. Conceptual model of healthcare access 
 
• Provider (“supply side”)  
o Approachability. Approachability refers to public information that the service 
exists, is able to be utilized, and can provide positive health outcomes to the target 
population(21). Transgender people often do not know of primary healthcare 
providers who are knowledgeable and/or nearby. Access to relevant healthcare 
information is a concern identified by the transgender community (6). Cruz 
identifies that this may cause patients to delay necessary healthcare until the point 
at which the health problem becomes severe enough to warrant emergency room 
treatment (10).  
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o Acceptability. This concept refers to any social/cultural beliefs about providing 
healthcare, and whether providing care to this population is socially sanctioned. 
The example given describes the healthcare-seeking behavior for some 
individuals of the Islamic faith, for whom physical contact between unmarried 
individuals of opposite genders is socially unacceptable. If the patient is a woman 
and the doctor a man, this may cause the provider to feel he is not able to provide 
care due to unacceptability (21). Health care providers may face discrimination 
from the community or from peers for providing care to gender minorities. This is 
a risk many providers accept, but could preclude others from providing such 
services.  
o Availability and accommodation. Even when healthcare services do exist and are 
acceptable, they may not be within a reasonable distance from a patient’s home or 
work, have necessary accommodations for those with a disability, employ 
providers with appropriate knowledge and credentials, or have appointments 
available within a reasonable amount of time (10, 21).  
o Affordability. While primary healthcare is often covered under insurance, many 
gender-affirming procedures and medications are not (22). Insurance policies also 
fail to cover biological sex-based care for those who have legally changed their 
gender: for example, a prostate exam for a woman (22).  Providers are limited in 
their ability to offer lower-cost services without reimbursement from insurance 
providers, government agencies, or private funding streams. To ensure the 
highest-quality services, providers need to be adequately compensated.  
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o Appropriateness. Appropriateness refers to provider adherence to established 
standards of care. An example is the circumstance of a transgender man seeking 
cervical care at a women’s healthcare clinic; the very nature of the health center 
implies that it is only for biological, cisgender women. Similarly, accepting 
attitudes and willingness of healthcare providers to learn about how to provide 
comprehensive trans healthcare play a large role in determining whether people 
will return for services or not (6). If a transgender man enters the clinic, gets 
misgendered as a woman, and feels his identity is being invalidated, this would be 
an example of inappropriate services.   
 
• Patient (“demand side”) 
o Ability to perceive. Individuals must first understand the need for preventive, 
primary, and emergency healthcare, and know that these levels of care exist. 
Much of this understanding comes from health literacy and is influenced by health 
beliefs (21). For the transgender population, patients may not be aware of 
biological screening recommendations (such as Pap smears), immunizations and 
preventive treatments (PrEP, HPV vaccine), or recommended tests for chronic 
health conditions that may be impacted by long-term hormone use (cardiovascular 
disease). Interviewees have reported that many doctors are also unaware of 
screening recommendations and long-term effects of gender-affirming surgeries 
(6). Even if the population is aware, they may not know who provides such care, 
or how to find this information.  
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o Ability to seek. This refers to the patient-side barrier of acceptability. As stated 
above, transgender people may not feel comfortable seeking care due to fear of 
mistreatment, or insecurity with their identity. The example of a transman seeking 
cervical care can be used here. If the individual understands that he should still be 
receiving regular Pap smears but does not feel comfortable presenting to a 
women’s health clinic or provider, then he would likely not receive the 
recommended screenings (6). The stigma surrounding an LGBTQ or trans-
specific healthcare clinic may prevent patients from obtaining care for fear that 
they will be “outed” socially, further marginalized, or seen to have a stigmatizing 
health condition (i.e. HIV).  
o Ability to reach. As stated above, many transgender individuals do not live within 
a reasonable distance from knowledgeable healthcare providers. Cruz proposed 
that transgender individuals may delay care based on inability to easily access 
care providers who are sensitive to their unique medical needs and trained to 
provide competent care for people who are gender expansive (10).  Survey 
participants often cite that not enough providers are trained to provide transgender 
care (5, 23).  
o Ability to pay. Income instability is cited by transgender survey participants as a 
main barrier to care (6). In this same small group of participants, 30% reported 
being unemployed or working poor (6). Based on the findings from the National 
Transgender Discrimination Survey (4), approximately 14% of the United States 
transgender population reports being unemployed. Reduced household income is 
associated in other populations with delaying medical care, as is a lack of 
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insurance (24). This puts the transgender population at greater risk of delaying 
medical care due to not having access to funds gained from employment, as well 
as employer-based insurance plans.  
o Ability to engage. This refers to an individual’s empowerment, information 
received, natural supports, and adherence to a regimen of treatment. Of course, 
every individual given healthcare recommendations has the option of declining 
adherence. However, for the transgender population there is a lower likelihood 
that they will receive familial support in their choices and treatment plans (4). 
Since the ability to engage is influenced by the level of support, either from others 
encouraging initial treatment or supporting the patient in receiving ongoing care, 
this puts people who are transgender at a disadvantage to continuing care.  
 
3.1.2 Delayed Medical Care 
 Many transgender people delay medical care, which can enhance risk for future medical 
conditions, worsen outcomes of existing conditions, and lead to increased cost of medical care 
(24). While the quantitative percentages are similar, significant qualitative differences exist 
between the transgender population and the general population when it comes to reasons for 
delaying medical care. One study showed that 33% of the general population delayed medical 
care over the last 12 months, due to a variety of factors (25). The top three reported reasons were 
not being able to take time off work, having to care for someone else, or not having 
transportation (25). Of the respondents, 3% indicated fear for personal safety. None reported 
discrimination as a factor. 
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In contrast, the National Transgender Discrimination Survey stratified respondents by 
their transgender status and found very reasons for delayed care (4). A quarter of study 
participants reported that they had delayed care due to fear of discrimination, with many having 
reported previous experiences of discrimination (Figure 4). Similarly, a report by Lambda Legal 
found the highest rates of fear among transgender individuals for being denied care or being 
treated differently due to trans status (Figure 5) (5). Compared with the general population, the 
reasons for delaying care in the transgender population paint a picture of risks outweighing the 
benefits of medical intervention.  
Figure 4. Postponement of preventive and emergency care 
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Figure 5. Fears and concerns about accessing healthcare 
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3.2 HEALTH SYSTEM DETERMINANTS 
The World Health Organization defines health system determinants as “the way health 
systems are designed, operate and financed” (26). For this section, the focus will remain on day-
to-day operations of healthcare settings and insurance policies, and how these impact people who 
are transgender.    
Traditionally the healthcare system restricts patients to binary gender (male or female) in 
medical forms, electronic health records, and research studies (9, 27). This makes it difficult for 
transgender patients to be recognized in ways that are not only medically relevant, but also 
socially validating. This is especially true for patients who have not undergone medical treatment 
and who may still present as their sex assigned at birth. This is important to show patients proper 
respect of their names and pronouns, but also to understand potential screening recommendations 
appropriate to someone’s anatomy.  
Insurance has historically been a barrier to quality care for transgender individuals. Prior 
to the Affordable Care Act (ACA), transgender identity, gender identity disorder, or gender 
dysphoria were all listed as “pre-existing conditions,” which could therefore result in health 
insurance denial (22). The ACA went into full implementation in 2014, removing the barrier of 
pre-existing conditions (22). Transgender adults seeking care prior to 2014 may have had a more 
difficult time accessing care, resulting in poorer health outcomes. Even once an individual has 
healthcare coverage, transition-related services remain difficult to access. Insurance companies 
may identify hormones, surgeries, and therapy to address gender dysphoria as “not medically 
necessary,” which may occur with higher frequency following the passage of the ACA (22). To 
 22 
this author’s knowledge, no research has been conducted to examine the frequency of insurance 
denials for gender-confirming care and qualitative reasons behind them. 
Despite positive changes in transgender healthcare instituted in the ACA, many health 
insurance providers retain practices that prohibit transgender individuals from obtaining needed 
healthcare, such as not covering transition-related services (22) or not performing routine 
screenings because biological sex differs from gender (6).  
3.3 MEDICAL KNOWLEDGE DEFICITS 
 Though transgender people are regular consumers of healthcare services and have been 
receiving medically complex care for decades, published research and available data do not 
match the current need for information, as evidenced by persistent health disparities experienced 
by people who are gender expansive. Pervasive discrimination among healthcare providers 
results in erasure of transgender people from research, expulsion from clinics not equipped or 
unwilling to provide care, and denial that transgender health issues are anything more significant 
than an anomaly among thousands. Indeed many providers adhere to outdated statistics regarding 
the number of transgender individuals, and in doing so, continue the institutional erasure that 
impedes quality care (6).  
 When established practices and treatment recommendations do exist, they are “often not 
incorporated into textbooks, educational curricula, health care protocols, or other summary 
documents, or [are] incorporated in a way that conflates gender identity with sexual orientation” 
(6). As already stated, gender identity is significantly different than sexual orientation, and as 
evidenced by the NTDS and Lambda Legal reports, much less easily understood (4, 5). These 
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reports and studies are not readily incorporated into information already being provided to 
healthcare providers; therefore, in order for a physician or medical professional to access the 
information, the person needs to know what to look for and where to find it.  
 Until recently, medical knowledge that did exist regarding transgender healthcare may 
have lacked accuracy and therefore been a hindrance to proper care. For example, recent 
evidence has brought to light the idea that estrogen may not protect against prostate cancer as 
previously believed (28). Historically, a literature review revealed only 10 known cases of 
prostate cancer in transwomen, which upheld the protective theory of estrogen. However, these 
10 cases constitute too small a sample size to support the conclusion of estrogen being 
protective. To date no known studies have compared prostate cancer rates in transgender women 
taking estrogen with cisgender men not taking estrogen. The researchers here argued that 
“patients in this cohort did not undergo regular screening, and therefore it is possible that 
subclinical cases were overlooked” (28). To have accurate estimates of disease incidence and 
prevalence, subclinical cases must be included in measures, and therefore anyone at risk for 
prostate cancer should be screened regularly. It can then be assessed whether transwomen 
receiving estrogen are at any qualitatively different risk for cancer than cisgender men. This will 
be revisited in the recommendations section of this paper.  
Surveys conducted among OBGYNs indicated that these providers were unable to 
identify any differences in pelvic examination processes between transgender men and cisgender 
women (29). The providers surveyed did not identify that a transgender man or non-binary 
person may experience higher levels of anxiety and discomfort during a pelvic exam, and may 
require additional supports during a procedure (29).  
 24 
Other studies show a higher likelihood for unsatisfactory Pap results for people who have 
been on androgen therapy and also retain a cervix (30). An unsatisfactory Pap is a sample that 
does not have enough cells or tissue to analyze for abnormalities. The medical assumption here is 
that the cervix/pelvic region of individuals receiving androgen therapy is qualitatively different 
than that of cisgender women. One idea postulated is that the cervix and vagina atrophy as the 
presence of estrogen is reduced within the body; certain treatments for post-menopausal 
cisgender women have been shown to be effective for collecting more satisfactory samples, but 
this has not been tested in transgender individuals. Inadequate Pap tests cause significant anxiety 
among all patients, regardless of gender identity, and this anxiety may cause longer delays 
between follow-up tests (30). Cisgender women tend to return for follow-up testing well within 
the recommended 4-month window following an abnormal Pap test, whereas transgender male 
patients (assigned female at birth, also referred to in the literature as FTM or FTX) wait 
significantly longer—in many cases, well over a year (30). In the absence of better information, 
the American College of Obstetrics and Gynecology (ACOG) recommends that patients who are 
transgender follow the same cervical screening guidelines as cisgender women, a fact that may 
have to be conveyed with greater importance to both patients and providers. This is especially 
important considering the higher prevalence of smoking and sexual violence among FTM and 
FTX individuals, both risk factors for cervical cancer (31). Another study supports this claim due 
to finding cases of cancer only incidentally when preparing FTM patients for sex-reassignment 
surgery (32); these cancer cases may have gone undetected without examination for a different 
medical procedure. At the time of the Urban study, the authors were only able to find 7 case 
studies over the last 10 years (2000-2010) addressing gynecologic malignancies in FTM patients 
(32). Such a diagnosis may lead not only to continued dysphoria among patients who retain 
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female sex organs, but may also cause insurance issues among those who have had their gender 
legally changed, and result in negative mental health consequences (32). It is of note that these 
mental health consequences should not deter a person from undergoing regular screenings and 
any treatment required, but that patients who identify as transgender or non-binary may require 
additional supports and follow-up compared with the general population (32). 
Medical knowledge is based in both ongoing research and education curricula. These are 
two areas in which representation of transgender people remains inadequate. A recent meta-
analysis explored the current trends in research focusing on the transgender population (33).The 
authors found only 116 studies globally that focused on the transgender population in any 
meaningful way (33). This study excluded studies that grouped the LGBTQ population into one 
group and did not stratify based on sexual orientation and/or gender identity. The authors 
identified 981 unique health outcomes, or data points (for example, diabetes would be one data 
point, as would be clinical depression). Many studies analyzed more than one health outcome. A 
thematic analysis separated these data points into six categories, listed in declining order of 
research density: mental health, sexual and reproductive health, substance use, 
violence/victimization, stigma/discrimination, and general health. Only 68 out of 981 datapoints 
(6.93%) related to general health, such as diabetes, heart disease, etc. This is of particular 
concern due to the dearth of knowledge related to long-term hormone use, different screening 
guidelines for health issues in transgender individuals, and the higher prevalence of health issues 
in other populations as a result of minority stress (33).  
 If we assess the declining research density as a model for the assumptions made about the 
transgender population, we see an implication that the concerns for people who are transgender 
are primarily those of substance abuse, mental illness, and what is perceived to be sexual 
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deviance. Recalling the discussion of stigma, these conditions compound negative connotations 
and lead to more stigmatizing conditions being assumed for the entire population of transgender 
people.  
 Transition-related care such as hormone treatments, masculinizing/feminizing surgeries, 
and sex-reassignment (also referred to as gender affirmation or gender confirmation surgery) 
have been studied significantly more in the medical community. Hembree et al. (34) discussed 
the current research and assessed recommendations along several domains relating to endocrine 
treatment. The researchers used the GRADE method (Grading of Recommendations, 
Assessment, Development, and Evaluation), an international method of establishing evidence-
based guidelines. The GRADE method uses a 4-point Likert scale, with 4 being the highest-
quality research according to systematic reviews conducted by third parties (34). The researchers 
analyzed two systematic reviews for consistency of findings and strength of evidence. Domains 
analyzed included service recommendations such as “We recommend that adolescents who 
fulfill eligibility and readiness criteria for gender reassignment initially undergo treatment to 
suppress pubertal development” (34). Each domain is a specific action to be taken with a patient 
meeting specific demographic criteria. Out of 24 domains listed, only 3 domains ranked at a 3 as 
far as existing research quality; that is to say, only 3 were considered to have “moderate quality” 
evidence (34). None of the domains were ranked at a 4 (“high quality”). A description of the 
GRADE method explains that a ranking of 4 would indicate the domain studied has received 
support in multiple RCTs that are strong and consistent across results. By contrast, a rating of a 2 
means that the existing research would have come from observational studies (instead of RCTs) 
or from RCTs that were flawed in their design (35). Despite the large number of studies further 
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research was needed across all domains to reach a level of high-quality medical knowledge and 
standards (34).  
A later analysis by the Center for Excellence in Transgender Health at UCSF expanded 
upon these treatment guidelines for adults and included non-binary people in their 
recommendations (36). These recommendations, while more comprehensive than the 
aforementioned study, still continue to focus almost exclusively on transition-related care. This 
includes important information such as reference levels for hormone injections, and side effects 
or complications of various surgeries (36). This information is accessible by general practitioners 
as opposed to only specialists, so in theory primary care providers can provide ongoing health 
maintenance instead of specialists.  
These analyses do not include information regarding conditions that affect the general 
population for which the transgender population may experience a difference in risk, such as 
heart disease. More of this will be discussed in the research recommendations section.  
3.3.1 Medical Education Deficits 
 The literature reflects a dearth of education among healthcare service workers, including 
doctors, nurses, desk staff, emergency responders, and specialty providers. This has been studied 
most frequently among OBGYNs. One study showed that 80% of OBGYNs did not receive 
formal training regarding people who are transgender while in their residency, even when latency 
since residency was considered. Providers who went through residency more recently were no 
more likely to have had training including transgender clients, indicating that education has not 
improved over time (29).   
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Referring back to the healthcare access model (21), this creates a gap in the number of 
available providers within reasonable distance from people who need care. This means the chain 
of access may be broken at both the availability/accommodation link and at the appropriateness 
of services link. Though screening recommendations exist for people with cervixes, it is not clear 
whether these practices are as effective at detecting cancers or abnormalities as they are in the 
general population.  
 Many studies focus only on LGBT sensitivity training, and few address the lack of 
training specific to people who are transgender. While transgender people are included in LGBT 
sensitivity training, healthcare experiences suggest that efficacy is significantly less for gender 
minorities. If the training was equally effective for sexual orientation minorities and gender 
minorities, the disparities in negative healthcare experiences would likely not exist, or would be 
significantly smaller than they are. The National Transgender Discrimination Survey and report 
on healthcare by Lambda Legal indicate that trainings have not been equally effective to ensure 
quality care (4, 5) 
 Emergency medicine is also resistant to including diverse populations in their training. 
Program directors for emergency medicine don’t often see a need for LGBT-inclusive residency 
training, and when they do, don’t know any interested faculty who are able to facilitate trainings 
(37). Indeed emergency medical staff may need to be more competent in treating transgender 
patients than most, since many transgender individuals delay care until an emergency condition 
develops (38).  
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3.3.2 Sensitivity Training and Effectiveness 
Evidence shows that there are some positive effects to sensitivity training. Among 
medical school students given four sessions regarding LGBTQ inclusive healthcare, many were 
able to provide qualitative feedback indicating that they felt better prepared to interact with this 
population (39). A Canadian study reported that sensitivity improved patient outcomes up to 1.5 
years after implementation of a randomized controlled trial (40). The limitations in this study 
indicated a need for further research to assess long-term outcomes for patients and providers 
following sensitivity training. For example, the authors state a lack of cultural diversity within 
the patient sample, indicating that more representation from minorities would be needed.  
3.4 DIAGNOSING VS. PATHOLOGISING TRANSGENDER PATIENTS 
Many transgender people seek gender confirmation through medical means. As stated by 
White Hughto et al., “The medicalization of gender nonconformity represents one form of 
structural stigma that shapes and reinforces perceptions of transgender people as deviant” (12). 
Historically these diagnoses have included titles such as gender identity disorder, now listed as 
gender dysphoria (41).  
Gender dysphoria as a diagnosis allows an ICD code to be utilized to bill for treatment. 
However, it takes the term “disorder” out of the name, thus eliminating some of the stigma 
attached to a diagnosis. Khan (22) summarizes this debate among the transgender community, 
within the medical community, and through the entanglement of legal definitions. While some in 
the transgender community oppose the idea that a medical definition needs to exist, others 
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identify it as a necessary means to an end—a way for insurance companies to provide 
compensation for transition-related care (22).  
3.5 ETHICS OF TRANSITION-RELATED CARE 
Healthcare providers identified ethics of transition-related care as being a barrier to 
providing quality care (20). Limited literature addresses ethics and those providers who refuse to 
provide transition-related care.  Studies have found that healthcare providers often express 
discomfort or refusal to perform care for transgender individuals. In one study 11% of doctors 
stated they were unwilling to perform Pap smears for transmen and 20% were unwilling to 
perform breast examinations for transwomen (29).  
 Recommendations from Hembree et al. deny that cross-sex hormones should be 
administered to pre-pubescent children (34). There are many current practitioners who opt for a 
reversible treatment known as puberty blockers. The concern of the authors is that many 
adolescents who experience gender dysphoria will experience remission, and return to gender 
congruence with sex assigned at birth. Practitioners are concerned about making changes to a 
child’s body, and indeed the recommendations now discourage surgical intervention on anyone 
under age 18 (34, 36).  
 Ethics can be extended to the insurance sector as well. It has been noted that the 
transgender population, in comparison with other groups, is a small group with limited political 
power on their own. An insurance company is designed to assess risk vs. risk—that is to say, risk 
of denying coverage to someone vs. risk of covering them for potentially expensive procedures 
and follow-up (22).  
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 It is unclear what the physicians surveyed were referring to when discussing ethics, and 
the extant literature does not explore this further. A comprehensive attitudes assessment has not 
been conducted to determine the ethical dilemmas facing medical providers when interacting 
with people who are transgender. Further qualitative inquiry is needed to clarify what is meant 
by ethical considerations.  
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4.0  RECOMMENDATIONS 
Over the past decade, multiple researchers have proposed recommendations for 
comprehensive care of transgender individuals within integrated healthcare systems. Despite the 
existence of standards of care published by WPATH and the Endocrine Society, many 
practitioners fail to incorporate these into their practice. Thus, transgender patients continue to be 
neglected and abused in healthcare settings, compounding the marginalization experienced 
within everyday life and causing detrimental health effects that research has only begun to 
explore. What follows is a synthesis of existing literature that categorizes recommendations and 
provides concrete action steps for healthcare providers. The need for extensive research is the 
final building block in creating a comprehensive system of care for transgender individuals. It 
cannot be emphasized enough how crucial transgender-specific trainings, protocols, and research 
are to the development of this field. Based on findings of within-group disparities, blanket 
policies and trainings covering the LGBT community are not enough to protect gender 
minorities.  
4.1.1 Transgender and gender-expansive sensitivity training 
Many organizations have adapted LGBTQ sensitivity trainings for their affiliates. These 
trainings are usually inclusive of the entire LGBTQ community, and very few concentrating only 
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on the transgender community are to be found. Samuel Lurie is one of the few people in the 
United States to provide exclusively transgender-specific, in-person training to healthcare 
providers (S. Lurie, personal communication, 2016). Mr. Lurie also conducted “Train-the-
Trainer” sessions in which he provided information to empower others to teach; however, he 
admitted that he had done few trainings since 2010. This author recommends that these types of 
trainings be incorporated to standard orientation and ongoing education, as they are a necessary 
component within the future of transgender healthcare.  
Reed (42) recommends face-to-face training for multiple types of professionals, and the 
model used could easily be applied to healthcare. More research is needed to see whether this 
approach can be adapted and brought to the United States, as its inception was in the United 
Kingdom. Research is needed to determine whether sensitivity training will be effective at 
changing healthcare attitudes and discrimination toward the transgender population (33).  
4.1.2 Creating an environment of inclusion 
Current standards of practice span the entirety of healthcare, from the initial conversation 
at the front desk of an office all the way through follow-up and insurance reimbursement. Coren 
et al. (43) describe a step-by-step approach that aims to address practitioners at all levels of 
knowledge and comfort with the LGBTQ community. The authors first recommend that 
providers evaluate their belief system, including any personal and/or religious opposition to 
transgender patients, and understand under which circumstances they become uncomfortable. 
These standards exist for transition-related care, but are limited in their recommendations for 
primary care. Providers should obtain information regarding standards of transition-related care 
from professional organizations, such as the American Medical Association, the World 
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Professional Association for Transgender Health, and the Endocrine Society (43). The healthcare 
provider should set aside the assumption of expertise, and allow the patient to educate them 
about health matters with which they are unfamiliar.  
A provider must recognize their own limitations when it comes to working with 
individuals and populations, and this should be assessed separately for sexual minorities and 
gender minorities (43). Until the provider becomes comfortable, the patient should be referred to 
someone who can treat them without personal bias. Risk factors must be assessed in a non-
judgmental way, which can be an uncomfortable conversation for both parties. Therefore 
providers without the skills and understanding necessary cannot be expected to assess these 
accurately. 
While patients identifying as lesbian, gay, or bisexual are often affiliated with those who 
identify as transgender, it should not be assumed that a blanket approach will be equally effective 
for sexual and gender minorities. The use of specific protocols is recommended when interacting 
with certain minority groups (9, 44). It is universally recommended that gender variant patients 
should have access to a private, unisex bathroom (9, 43, 45). Patients admitted as inpatients 
should have the option of a private room for safety reasons, or should share a room with a patient 
of the same gender identity (9). Offices can also show support by hanging up symbols of 
advocacy organizations and posters showing diverse patient populations. Ensuring that a 
practice’s non-discrimination policy is visible is also helpful in making patients feel welcome 
(43). Something as simple as subscribing to LGBTQ magazines can help patients see themselves 
represented in waiting room literature (43).  
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4.1.3 Medical Forms and Records 
Significant emphasis is placed on medical forms, and the ways in which these can be 
designed to accommodate any variation of gender and/or sexual orientation (9). There are several 
examples of appropriately inclusive forms. For example, sex and gender are two separate 
categories but are not often separated on paperwork according to the literature (43, 46). 
Electronic health records still pose a challenge, but intake forms can be modified for each office 
or organization.  
 The Institute of Medicine (IOM) and the World Professional Association for Transgender 
Health (WPATH) have collaborated on developing electronic health record systems that are able 
to properly record gender identity and transgender status (9). This would allow a patient’s 
accurate gender identity as well as accurate physiology to be present in the medical record. 
Laboratory information systems should also reflect gender identity, and may be different from 
other electronic health records. A transgender patient’s hormone levels may differ from reference 
levels for a cisgender patient, and these would be framed in the laboratory information system 
(9).  
 Coding and billing are essential to the delivery of medical care in the United States. 
However, concern has been raised regarding the use of transgender as a diagnosis. Recently, the 
Diagnostic and Statistical Manual of the American Psychological Association, Fifth Edition 
(DSM-V) has removed the diagnosis “gender identity disorder” and replaced it with “gender 
dysphoria.” While the former implies that the patient has a disorder because of gender 
incongruence, the latter implies that societal factors including gendered behavioral expectations 
result in distress among people whose gender identity does not align with their sex assigned at 
birth.  
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 Using gender dysphoria as a diagnosis, clinicians could consider using a natural history 
of disease model to show the outcomes of various presentations and treatments for this specific 
condition. If we can utilize a medical model like one pictured below, it is possible we can view 
the various courses of treated and untreated gender dysphoria (including possible outcomes of 
death and spontaneous remission) the same way we view infections, cancers, depression, etc. 
This would no longer indicate that being transgender is an illness, but rather show how 
transition-supportive care can lead to better health outcomes in those with gender dysphoria. The 
first model (Figure 6) shows the natural history of untreated gender dysphoria. The second model 
(Figure 7) shows where treatment interventions can lead to positive natural outcomes, or create a 
new positive outcome as a result of treatment.   
 
 
Figure 6. Medical model demonstrating the natural history of untreated gender dysphoria 
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Figure 7. Outcomes of gender dysphoria when treatment is introduced 
 
4.1.4 General Care Recommendations 
Transgender patients, like all patients, should be receiving regular primary care, including 
recommended vaccinations, physical exams, blood work as needed, and any necessary specialty 
care unrelated to transition-based procedures. Increased risk factors for certain illnesses and 
conditions make comprehensive, integrated care a necessity. Careful attention should be paid to 
chronic disease risk, as the levels of risk for these illnesses are largely unstudied in this 
population (33).  
 Standard medical screening guidelines apply to all patients regardless of gender identity. 
Providers must be aware if their patients retain sex organs after surgical intervention, as these are 
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still at risk for cancers and other conditions that may be overlooked if a patient is unaware of 
screening guidelines. “Regardless of gender identity, any individual with these organs needs and 
deserves the same medical care for them, thus the frequent transgender preventative care adage, 
‘if you have it, screen it’” (7).  
 Endocrinologists have concluded that transgender women should be getting breast exams 
similar to cisgender women, to screen for breast cancer (9). Transgender men should also receive 
Pap smears and pelvic exams at the same frequency as cisgender women (36, 45).  
4.1.5 Insurance policy modification 
In reference to billing issues regarding a patient’s legal name vs. chosen name, all 
insurance companies should have the ability to list a patient’s preferred name first, followed by 
one’s legal name for payment, identification, etc. This would allow the patient to be properly 
addressed and feel respected by insurance staff, feel more recognized as their true self, and have 
flexibility to change their legal name when they have the financial resources, emotional energy, 
and time to go through the process of doing so. Medical and insurance forms can be flexible and 
validating, while still adhering to legal standards that bind a patient contractually for payment.  
 Insurance policies must reflect a commitment to supporting gender-affirming care, and 
not deny coverage based on “lack of medical necessity” (22). Policies should also include non-
discrimination clauses for gender minorities; this has been applied to hospital settings, but should 
be extended to insurance companies as well (46).  
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4.1.6 Adding to medical school curricula 
Most patients have identified that more providers are needed who are educated in 
transgender healthcare. Medical students acknowledge the deficits in their education, and find 
training specific to transgender patients useful and relevant. Many believe this should be 
incorporated into medical school curricula (33, 39).  
 There are two ways to incorporate gender variance into medical school curricula. The 
first method is to have specific courses or training programs relating to the transgender 
community—a medical competency training at the university level. Medical students are more 
likely to feel competent, and report improved knowledge, skills, and attitudes (based on self-
report), following more than 2 hours of transgender-specific education (47).  
The second method, which this author recommends, is the idea of mainstreaming. In this 
scenario, students would have transgender patients periodically in classroom examples, who may 
or may not be seeking care related to their status as a transgender person. Even those with a self-
identified “conservative” approach to transgender treatment believe that it is essential to 
incorporate these issues into standard medical education and practice (48).  
4.1.7 Research needed 
Despite recent efforts by the Williams Institute (2), formal epidemiological 
measurements of the gender-expansive population have not yet been conducted. This would 
include incidence and prevalence studies, which would give a more accurate picture of the 
population demographics (9). Cohort studies should be conducted to determine more in-depth 
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information. This would supplement a “life course approach” to transgender healthcare that is 
not currently in practice (9).   
 It is of note that many existing studies address the LGBTQ community as a whole, and 
did not separate the transgender portion of the community. Research featuring transgender or 
gender expansive participants is often lumped in with the rest of the LGBTQ community, and 
does not always stratify based on orientation vs. identity. This eliminates much knowledge of 
within-group disparities. Even those studies that do separate based on transgender status often do 
not acknowledge the differences within the transgender community (49). While one researcher is 
leading studies of transmasculine individuals through the Fenway Institute in Massachusetts (50), 
it is unclear whether similar studies are being conducted among other transgender populations or 
in other geographic locations. This presents an opportunity for research of specific identities, not 
just transgender people in general. Studies should stratify by binary vs. non-binary identities, and 
compare health outcomes across these groups. Cruz recommends utilizing the following 
categories, starting with sex assigned at birth, and ending with current gender identity: female-to-
male (FTM); male-to-female (MTF); female-to-other (FTX); male-to-other (MTX) (10). This 
would indicate whether assigned sex has any bearing on the outcome, but also would show the 
varying identities of participants. Additional identity categories should be available for 
participants to self-identify. Other researchers support this two-step method, and emphasize the 
need to include those not diagnosed with gender identity disorder or gender dysphoria, and those 
with non-binary identities (16, 33). None of these categories are typically captured within 
existing research.  
 Studies of other minority groups shed light on some of the challenges faced by 
researchers. Majumdar et al. (40) recommend a longer study period to capture more participants 
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who may utilize healthcare with less frequency than the general population. Studies should also 
focus on the impact of minority stress on substance use, mental health issues, and other general 
health concerns (33).  
 There are specific health conditions that affect the transgender community, but more 
research is needed to determine risk ratios and associated factors. There have not been formal 
randomized controlled trials that examine long-term use of hormone replacement therapy (HRT) 
(9). Some research has suggested differences in blood pressure, cholesterol levels, and BMI as a 
result of cross-sex hormone administration, but this has yet to be rigorously studied such that 
clinical guidelines can be developed (13).  
While the presence or absence of sexually transmitted infections is often assessed in 
research, there are limited studies addressing reproductive health issues not related to infectious 
disease (7, 33, 45). This includes studies involving the incidence and prevalence of cervical 
abnormalities among FTM and FTX individuals (30). Because of the challenges in collecting 
cervical samples among these populations, strategies for reducing inadequate Pap results in FTM 
and FTX patients should also be explored (30).  
Much research has focused on suicide and depression risk among transgender people, but 
other mental health conditions and their prevalence in these populations have received less 
attention (33). Transgender individuals may be at higher risk for body image disorders and eating 
disorders due to body dysmorphia, and research should be conducted to determine the level of 
risk compared to the general population (33). Studies of post-traumatic stress disorder and acute 
stress disorders should also be conducted due to higher rates of abuse and trauma among these 
populations (4, 33). Further assessment of the types of abuse and multiple dimensions of such 
abuse, including verbal and emotional abuse, is also needed (33).  
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 The relationship between providers and patients is a critical element of any healthcare 
interaction. While some of this has been explored among the general population or other 
minorities, very little has been conducted with the transgender population. More information is 
needed regarding trust issues between gender minority patients and their providers (24). Mixed-
method research on patient-provider interactions is recommended to accurately capture data 
regarding what constitutes a welcoming or unwelcoming provider (23).  
To date, no studies have been done assessing gender spectrum differences in emergency 
healthcare experience (44). Alongside this, studies of emergency room experiences must include 
a full range of positive and negative experiences within emergency department settings (44). 
Many studies focus only on negative experiences, instead of identifying what creates a positive 
experience.  
Existing models can utilize gender exposure as an independent variable for health 
outcomes. Current epidemiological frameworks such as a vulnerability matrix would be effective 
in gauging the impact of various gender identity exposures (as opposed to only sex assigned at 
birth) in health outcomes, and whether gender experience varies throughout the life course. 
These models should be certain to include non-binary identities and gender nonconforming 
individuals, and assess whether binary vs non-binary identities have significant differences in 
health outcomes (16).  
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5.0  DISCUSSION 
While rigorous research still lacks in many areas, current practitioners support many of 
the ideas presented in this paper. Additional information was obtained through audio podcasts, 
conference presentations attended by the author, individual interviews conducted between 2015 
and 2018, and networking with local transgender individuals and LGBTQ advocates.  
Pubertal hormone blockers are currently being used locally by the Gender and Sexual 
Development Program at Children’s Hospital of Pittsburgh. Per conversation with nurse 
practitioner Joanne Goodall, a local leader in the transgender health field, this treatment is 
helpful in blocking the development of irreversible secondary sex characteristics that can lead to 
extreme dysphoria in individuals who are transgender (51). The advantage of blockers as 
opposed to cross-sex hormones is that the blockers cause no known permanent effects, except to 
delay the onset of puberty. While practitioners report that this is not something that is healthy 
long-term, family members and healthcare consumers agree that this allows the patient some 
extra time to consider a physical transition without being forced to develop in ways they may not 
want (52). In the absence of further information, this is considered best practice.  
None of the local individuals providing interviews in the Greater Pittsburgh area 
expressed concerns for their own safety solely for providing care to transgender individuals. 
However, recently laws in other states such as North Carolina have given practitioners cause for 
concern. As Dr. Deanna Adkins, a pediatric endocrinologist from the Duke Child and Adolescent 
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Gender Care clinic pointed out, staff may be a target for violence due to providing care for 
transgender children. Dr. Adkins made it clear during this interview that her main concern was 
for the safety of her patients, due to the social determinants of health described earlier in this 
paper (53).  
This paper has not addressed the intersectional concerns of the community. While the 
challenges facing the transgender population can be consistent across subpopulations, it should 
not be assumed that people of different racial groups, religions, and socioeconomic statuses share 
identical experiences. Furthermore the experiences within and across the aforementioned groups 
may differ based on binary vs. non-binary identities, and gender nonconforming vs. transgender 
individuals (16).  
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6.0  CONCLUSION 
 Safe, reliable, and effective healthcare services are needed for transgender individuals, 
who face barriers to accessing care at all levels. Specific actions must be taken by the medical 
community to address the health disparities faced by transgender and gender-variant individuals, 
and this includes a comprehensive understanding of what those disparities are. While there is 
much information regarding HIV/AIDS, substance abuse, and mental health disorders, too little 
research has focused on primary and preventive medicine as a method of health maintenance and 
disease prevention in this population. Scientifically rigorous studies could help to highlight 
within-group differences among the transgender population, and aim to find solutions to health 
disparities faced by this group.  
 Medical staff at all levels should have the knowledge and skills to treat transgender 
patients regardless of the point at which healthcare is accessed. These professionals should be 
granted the opportunity for continuing education focused on the development of sensitivity 
toward people who are gender expansive. Formal training and research methods should be 
developed by professionals and thoroughly evaluated throughout implementation. The 
recommendations shown here serve as a guide for the future of medical care and education to 
better serve transgender patients.  
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APPENDIX: TERMS AND DEFINITIONS 
These terms and their definitions have been adapted from the literature used in this review 
Gender congruence: Condition when gender identity matches sex assigned at birth; these 
people are known as cisgender individuals 
Gender dysphoria: Anxiety, depression, and other distress caused by gender incongruence, 
social expectations, mental health conditions, and minority stress 
Gender expansive**: a way to encompass all non-cisgender identities, including those who do 
not identify as transgender 
Gender non-conforming: Individuals who identify as cisgender, but do not adhere to the typical 
gender norms or expectations of their assigned gender 
Gender incongruence: Condition when gender identity does not match sex assigned at birth 
Non-binary: An identity that is neither male nor female, also called gender-neutral, 
genderqueer, or agender 
Transgender: For the purposes of research and consistency, this is a term used to describe 
anyone whose gender identity is incongruent with their sex assigned at birth.  
Trans*: (Asterisk included) Sometimes used as an umbrella term to describe the trans spectrum, 
encompassing non-binary identities and those of fluid gender identity 
 
**Used in practice but not yet seen in literature 
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